Insider filing · ORIC
Jacob Chacko
PRESIDENT AND CEO
profile →
ORIC Pharmaceuticals, Inc.
ORIC · Healthcare · 12 filings in 24 months
ticker →
Jacob Chacko sold $1.4M of ORIC Pharmaceuticals (ORIC)
Executed Sep 22 2025, disclosed Sep 24 2025, 2 days later.
Value, as filed
$1.4M
125,000 sh × $10.80
Executed
Sep 22 2025
the trade date, as filed
Disclosed
Sep 24 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JCJacob Chacko (PRESIDENT AND CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in ORIC Pharmaceuticals, Inc. (ORIC). The largest single filing was $302K of ORIC (33,374 sh × $9.06, as filed), executed Dec 16 2025.
The name
ORICHealthcare · ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jacob Chacko in ORIC
ORICSALE
ORIC Pharmaceuticals, Inc.
$302K33,374 sh × $9.06
Exec Dec 16 2025
Filed Dec 17 2025 · 5:30 PM ET ORICSALE ORIC Pharmaceuticals, Inc. $462K
37,461 sh × $12.32
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET ORICSALE ORIC Pharmaceuticals, Inc. $1.1M
87,539 sh across 2 lots
Exec Sep 30 2025
Filed Oct 2 2025 · 5:30 PM ET ORICSALE ORIC Pharmaceuticals, Inc. $204K
24,660 sh × $8.28
Exec Dec 16 2024
Filed Dec 17 2024 · 5:30 PM ET